{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:42:49Z","timestamp":1791812569311,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.euo.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T00:16:15Z","timestamp":1562804175000},"page":"515-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies"],"prefix":"10.1016","volume":"2","author":[{"given":"Nicholas G.","family":"Zaorsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Lehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gargi","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander V.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar","family":"Siva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2019.05.007_bib0270","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1001\/jama.281.17.1628","article-title":"Rising incidence of renal cell cancer in the United States","volume":"281","author":"Chow","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2019.05.007_bib0275","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-5347(17)44873-7","article-title":"Prognostic factors in metastatic renal carcinoma","volume":"136","author":"Maldazys","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2019.05.007_bib0280","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2019.05.007_bib0285","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ctrv.2007.12.001","article-title":"Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review","volume":"34","author":"Gupta","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.euo.2019.05.007_bib0290","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2217\/fon.14.40","article-title":"Extracranial oligometastatic renal cell carcinoma: current management and future directions","volume":"10","author":"Loh","year":"2014","journal-title":"Future Oncol"},{"key":"10.1016\/j.euo.2019.05.007_bib0295","doi-asserted-by":"crossref","first-page":"15690","DOI":"10.18632\/oncotarget.3704","article-title":"Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancer","volume":"6","author":"Meng","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.euo.2019.05.007_bib0300","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","article-title":"American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy","volume":"76","author":"Potters","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2019.05.007_bib0305","series-title":"Kidney cancer, version 3.2019","author":"Motzer","year":"2019"},{"key":"10.1016\/j.euo.2019.05.007_bib0310","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3171\/spi.2005.3.4.0288","article-title":"Stereotactic radiosurgery for spinal metastases from renal cell carcinoma","volume":"3","author":"Gerszten","year":"2005","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.euo.2019.05.007_bib0315","first-page":"e6","article-title":"The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT)","volume":"3","author":"Teh","year":"2007","journal-title":"Biomed Imaging Interv J"},{"key":"10.1016\/j.euo.2019.05.007_bib0320","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ijrobp.2009.03.062","article-title":"Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy","volume":"76","author":"Nguyen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2019.05.007_bib0325","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3171\/2012.8.SPINE12303","article-title":"Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma","volume":"17","author":"Balagamwala","year":"2012","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.euo.2019.05.007_bib0330","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3109\/0284186X.2011.652741","article-title":"A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases","volume":"51","author":"Jhaveri","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.euo.2019.05.007_bib0335","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/COC.0b013e31825d52b2","article-title":"Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma","volume":"36","author":"Ranck","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.euo.2019.05.007_bib0340","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.ijrobp.2011.02.040","article-title":"Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma","volume":"82","author":"Zelefsky","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2019.05.007_bib0345","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijrobp.2017.01.032","article-title":"Safety and efficacy of stereotactic ablative radiation therapy for renal cell carcinoma extracranial metastases","volume":"98","author":"Wang","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2019.05.007_bib0350","first-page":"372","article-title":"Brain metastases in renal cell carcinoma: management with Gamma Knife radiosurgery","volume":"6","author":"Amendola","year":"2000","journal-title":"Cancer J"},{"key":"10.1016\/j.euo.2019.05.007_bib0355","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0360-3016(00)00536-8","article-title":"The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastases from renal cell carcinoma","volume":"47","author":"Goyal","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2019.05.007_bib0360","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3171\/jns.2000.92.5.0760","article-title":"Gamma surgery for intracranial metastases from renal cell carcinoma","volume":"92","author":"Payne","year":"2000","journal-title":"J Neurosurg"},{"issue":"5 Suppl.","key":"10.1016\/j.euo.2019.05.007_bib0365","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3171\/jns.2002.97.supplement_5.0489","article-title":"Gamma Knife radiosurgery for renal cell carcinoma brain metastases","volume":"97","author":"Hernandez","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1016\/j.euo.2019.05.007_bib0370","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/cncr.23857","article-title":"Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery","volume":"113","author":"Samlowski","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2019.05.007_bib0375","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1227\/NEU.0b013e31822b2fdc","article-title":"Outcome predictors of Gamma Knife radiosurgery for renal cell carcinoma metastases","volume":"69","author":"Kano","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.euo.2019.05.007_bib0380","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3171\/2012.2.JNS111353","article-title":"The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery","volume":"116","author":"Cochran","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1016\/j.euo.2019.05.007_bib0385","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.radonc.2005.03.022","article-title":"Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma","volume":"77","author":"Wersall","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.euo.2019.05.007_bib0390","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1464-410X.2010.09895.x","article-title":"Simultaneous anti-angiogenic therapy and single-fraction radiosurgery in clinically relevant metastases from renal cell carcinoma","volume":"108","author":"Staehler","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2019.05.007_bib0395","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2004-818511","article-title":"Stereotactic radiosurgery without radiation therapy providing high local tumor control of multiple brain metastases from renal cell carcinoma","volume":"47","author":"Muacevic","year":"2004","journal-title":"Minim Invasive Neurosurg"},{"key":"10.1016\/j.euo.2019.05.007_bib0400","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00066-010-2055-z","article-title":"Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?.: analysis of 88 patients","volume":"186","author":"Fokas","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.euo.2019.05.007_bib0405","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2018.04.008","article-title":"Stereotactic radiation therapy in the strategy of treatment of metastatic renal cell carcinoma: a study of the GETUG group","volume":"98","author":"Meyer","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.euo.2019.05.007_bib0410","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1078-1439(03)00104-2","article-title":"LINAC radiosurgery for brain metastasis of renal cell carcinoma","volume":"22","author":"Noel","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2019.05.007_bib0415","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.radonc.2018.04.028","article-title":"Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005\u20132014","volume":"127","author":"Stenman","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.euo.2019.05.007_bib0420","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.juro.2018.08.049","article-title":"Role of stereotactic body radiation therapy for the management of oligometastatic renal cell carcinoma","volume":"201","author":"Franzese","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2019.05.007_bib0425","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s007010050139","article-title":"Gamma-Knife radiosurgery for brain metastases of renal cell carcinoma: results in 23 patients","volume":"140","author":"Schoggl","year":"1998","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.euo.2019.05.007_bib0430","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0360-3016(00)00804-X","article-title":"Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma","volume":"48","author":"Ikushima","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2019.05.007_bib0435","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1046\/j.1442-2042.2002.00531.x","article-title":"Gamma-Knife radiosurgery for brain metastasis of renal cell carcinoma: results in 42 patients","volume":"9","author":"Hoshi","year":"2002","journal-title":"Int J Urol"},{"key":"10.1016\/j.euo.2019.05.007_bib0440","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11060-010-0170-4","article-title":"Treatment strategy for metastatic brain tumors from renal cell carcinoma: selection of Gamma Knife surgery or craniotomy for control of growth and peritumoral edema","volume":"98","author":"Shuto","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/j.euo.2019.05.007_bib0445","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.ijrobp.2011.03.044","article-title":"Early significant tumor volume reduction after radiosurgery in brain metastases from renal cell carcinoma results in long-term survival","volume":"82","author":"Kim","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2019.05.007_bib0450","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/02841860600954875","article-title":"A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma","volume":"45","author":"Svedman","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.euo.2019.05.007_bib0455","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/0284186X.2014.939298","article-title":"Outcomes of stereotactic radiotherapy for cranial and extracranial metastatic renal cell carcinoma: a systematic review","volume":"54","author":"Kothari","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.euo.2019.05.007_bib0460","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/annonc\/mdq028","article-title":"Need for a new trial to evaluate postoperative radiotherapy in renal cell carcinoma: a meta-analysis of randomized controlled trials","volume":"21","author":"Tunio","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euo.2019.05.007_bib0465","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fonc.2012.00104","article-title":"In the field: exploiting the untapped potential of immunogenic modulation by radiation in combination with immunotherapy for the treatment of cancer","volume":"2","author":"Kwilas","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2019.05.007_bib0470","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nrurol.2017.87","article-title":"Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach","volume":"14","author":"Siva","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.euo.2019.05.007_bib0475","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/s41591-018-0232-2","article-title":"Radiotherapy induces responses of lung cancer to CTLA-4 blockade","volume":"24","author":"Formenti","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.euo.2019.05.007_bib0480","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1158\/0008-5472.CAN-10-2820","article-title":"The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity","volume":"71","author":"Burnette","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.euo.2019.05.007_bib0485","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.euo.2019.05.007_bib0490","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2018.08.025","article-title":"Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: an international meta-analysis of individual patient data","volume":"130","author":"Lehrer","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.euo.2019.05.007_bib0495","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.3390\/ijms19103054","article-title":"Stereotactic radiosurgery and immune checkpoint inhibitors in the management of brain metastases","volume":"19","author":"Lehrer","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.euo.2019.05.007_bib0500","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijrobp.2018.10.038","article-title":"Single versus multifraction stereotactic radiosurgery for large brain metastases: an international meta-analysis of 24 trials","volume":"103","author":"Lehrer","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Pt 1","key":"10.1016\/j.euo.2019.05.007_bib0505","first-page":"746","article-title":"Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: support for dose escalation based on a biological model","volume":"158","author":"DiBiase","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2019.05.007_bib0510","doi-asserted-by":"crossref","first-page":"439752","DOI":"10.1155\/2011\/439752","article-title":"The confluence of stereotactic ablative radiotherapy and tumor immunology","volume":"2011","author":"Finkelstein","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.euo.2019.05.007_bib0515","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.canlet.2016.02.033","article-title":"Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy","volume":"375","author":"Wang","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.euo.2019.05.007_bib0520","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ccr.2005.07.014","article-title":"Engaging the vascular component of the tumor response","volume":"8","author":"Fuks","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.euo.2019.05.007_bib0525","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijrobp.2018.01.036","article-title":"Ablative hypofractionated radiation therapy enhances non-small cell lung cancer cell killing via preferential stimulation of necroptosis in vitro and in vivo","volume":"101","author":"Wang","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2019.05.007_bib0530","doi-asserted-by":"crossref","first-page":"57391","DOI":"10.18632\/oncotarget.10548","article-title":"Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy","volume":"7","author":"Meng","year":"2016","journal-title":"Oncotarget"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931119300744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931119300744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:46:09Z","timestamp":1762875969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931119300744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S2588931119300744"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2019.05.007","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}